Up-regulation of DHRS4-AS1 in HCC cells demonstrated significant reduction of Bcl-2, Bcl-xl and Cyclin-D1, but the abundance of Bax increased (Figure 2(g)). This evidence concerns the gene BCL2 and hepatocellular carcinoma.